Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Integrin β3 is seen as a key anti-angiogenic target for cancer treatment due to its expression on neovasculature, but the role it plays in the process is complex; whether it is pro- or anti-angiogenic depends on the context in which it is expressed. To understand precisely β3's role in regulating integrin adhesion complexes in endothelial cells, we characterised, by mass spectrometry, the β3-dependent adhesome. We show that depletion of β3-integrin in this cell type leads to changes in microtubule behaviour that control cell migration. β3-integrin regulates microtubule stability in endothelial cells through Rcc2/Anxa2-driven control of active Rac1 localisation. Our findings reveal that angiogenic processes, both in vitro and in vivo, are more sensitive to microtubule targeting agents when β3-integrin levels are reduced. © 2018 The Authors. Published under the terms of the CC BY 4.0 license.

Citation

Samuel J Atkinson, Aleksander M Gontarczyk, Abdullah Aa Alghamdi, Tim S Ellison, Robert T Johnson, Wesley J Fowler, Benjamin M Kirkup, Bernardo C Silva, Bronwen E Harry, Jochen G Schneider, Katherine N Weilbaecher, Mette M Mogensen, Mark D Bass, Maddy Parsons, Dylan R Edwards, Stephen D Robinson. The β3-integrin endothelial adhesome regulates microtubule-dependent cell migration. EMBO reports. 2018 Jul;19(7)

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 29794156

View Full Text